Stock Groups

Pfizer’s COVID-19 vaccine trial data shows long-term efficacy in adolescents -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO: A syringe is stuffed with a dose of Pfizer’s COVID-19 vaccine at a pop-up group vaccination heart on the Gateway World Christian Middle in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermid

(Reuters) -Pfizer Inc mentioned on Monday its COVID-19 vaccine supplied sturdy long-term safety towards the virus in a late-stage examine carried out amongst adolescents aged 12 to fifteen years.

A two-dose collection of the vaccine was 100% efficient towards COVID-19, measured seven days by over 4 months after the second dose, the corporate mentioned.

The long-term information will help deliberate submissions for full-regulatory approval of the vaccine within the age group in america and worldwide.

Pfizer (NYSE:) and BioNTech will search clearance for a 30 micrograms dose of the vaccine for these aged 12 and above.

The vaccine was approved for emergency use in folks aged 12-15 years by the U.S. Meals & Drug Administration in Could, and granted full approval to be used in folks aged 16 and above in August.

Disclaimer: Fusion Media wish to remind you that the information contained on this web site will not be essentially real-time nor correct. All CFDs (shares, indexes, futures) and Foreign exchange costs will not be supplied by exchanges however relatively by market makers, and so costs is probably not correct and should differ from the precise market value, which means costs are indicative and never applicable for buying and selling functions. Due to this fact Fusion Media doesn`t bear any duty for any buying and selling losses you would possibly incur because of utilizing this information.

Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or injury because of reliance on the knowledge together with information, quotes, charts and purchase/promote alerts contained inside this web site. Please be absolutely knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding varieties attainable.

[ad_2]